
Clarithromycin
Clarithromycin prevented MAC infection in people with advanced AIDS (6% versus 16% on placebo) and reduced deaths, and it is part of some H. pylori regimens, although a 7-day clarithromycin triple therapy cleared only 55% of infections in a large European trial and US guidance now prefers other first choices. A 2-week course in people with stable coronary heart disease increased cardiovascular deaths. Red yeast rice is the main supplement issue.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Adults and children with a bacterial infection their prescriber expects clarithromycin to treat, people with advanced HIV who need MAC treatment or prevention, and selected H. pylori regimens
Common dosing range
Set by your prescriber. The tablet label gives 250 to 500 mg every 12 hours for 7 to 14 days for most adult infections, 500 mg every 12 hours for MAC, and 500 mg every 8 to 12 hours for 10 to 14 days in H. pylori combinations; children 15 mg/kg a day in two doses
When to expect effects
Courses of 7 to 14 days for most infections; MAC prevention is continued long term
Watch out for
Dangerous interactions through CYP3A4: colchicine (fatal cases), simvastatin and lovastatin (contraindicated), some calcium channel blockers, warfarin and others. Also QT prolongation, liver injury, C. difficile diarrhea, worse myasthenia gravis, and higher long-term mortality seen in people with heart disease
What is it
Clarithromycin is a prescription macrolide antibiotic sold as generic tablets, extended-release tablets and an oral suspension (the original brand was Biaxin). The label approves it for mild to moderate bacterial infections, including some chest, sinus, throat, skin and ear infections, for treating and preventing Mycobacterium avium complex (MAC) infection in people with advanced HIV, and, combined with other drugs, for clearing Helicobacter pylori to reduce the return of duodenal ulcers. The label calls it a strong blocker of the CYP3A4 enzyme, which is why it has so many serious drug interactions.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
preventing MAC infection in advanced AIDS Good Evidence | About 69% fewer MAC infections and 25% lower risk of death over about 10 months | People with advanced HIV and very low CD4 counts | Benefit seen over months of daily use |
Helicobacter pylori eradication (triple therapy) Good Evidence | About 55% eradication with 7-day triple therapy in one European trial | Adults with H. pylori known or likely to be clarithromycin-susceptible | Cure confirmed by breath test 4 to 8 weeks after treatment |
stable coronary heart disease (off-label, not effective) Good Evidence | No benefit; about 27% higher risk of death over 3 years | Not applicable: no group with heart disease benefited | Harm seen over 1 to 10 years after a 2-week course |
preventing MAC infection in advanced AIDS
- Effect
- About 69% fewer MAC infections and 25% lower risk of death over about 10 months
- Best fit
- People with advanced HIV and very low CD4 counts
- Time
- Benefit seen over months of daily use
Helicobacter pylori eradication (triple therapy)
- Effect
- About 55% eradication with 7-day triple therapy in one European trial
- Best fit
- Adults with H. pylori known or likely to be clarithromycin-susceptible
- Time
- Cure confirmed by breath test 4 to 8 weeks after treatment
stable coronary heart disease (off-label, not effective)
- Effect
- No benefit; about 27% higher risk of death over 3 years
- Best fit
- Not applicable: no group with heart disease benefited
- Time
- Harm seen over 1 to 10 years after a 2-week course
Evidence for 3 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
preventing MAC infection in advanced AIDS
Disease adjunctA double-blind trial in the US and Europe randomly assigned 667 people with AIDS and CD4 counts of 100 or less to clarithromycin 500 mg twice daily or placebo. It was stopped after the first interim analysis: MAC infection developed in 6% on clarithromycin versus 16% on placebo (adjusted hazard ratio 0.31). Over about 10 months, 32% versus 41% died (hazard ratio 0.75). In 11 of the 19 people who still developed MAC on clarithromycin, the bacteria were resistant to it. Taste changes were more common on clarithromycin. The trial was done in the 1990s, before modern HIV treatment.
Bottom line: Clarithromycin prevented MAC infection and lowered deaths in people with advanced AIDS.
Helicobacter pylori eradication (triple therapy)
Disease adjunctClarithromycin is approved with amoxicillin and a proton pump inhibitor to clear H. pylori, but resistance has cut its success. In a European trial of 440 adults, 7 days of omeprazole, amoxicillin and clarithromycin cleared the infection in 55% (123 of 222), versus 80% with 10 days of bismuth quadruple therapy (intention to treat). The 2024 American College of Gastroenterology guideline prefers 14 days of bismuth quadruple therapy for first treatment when antibiotic susceptibility is unknown, and says clarithromycin salvage regimens should be used only when susceptibility is confirmed.
Bottom line: Clarithromycin triple therapy still clears many H. pylori infections, but resistance makes it a weaker first choice than bismuth quadruple therapy.
stable coronary heart disease (off-label, not effective)
No benefit foundOff-label use: the label says treating coronary artery disease is not an approved use. The CLARICOR trial randomly assigned 4,373 Danish adults with stable coronary heart disease to 2 weeks of clarithromycin 500 mg a day or placebo. Over 3 years it did not reduce the combined rate of death, heart attack or unstable angina (hazard ratio 1.15), and deaths were higher on clarithromycin (hazard ratio 1.27), driven by cardiovascular deaths (1.45). At 10 years, all-cause mortality remained higher (1.10), and the increase was confined to people not taking a statin at entry. The label now warns about higher mortality one year or more after treatment in people with coronary artery disease.
Bottom line: A short clarithromycin course did not help people with stable coronary heart disease and was followed by more deaths.
How it works
How to take it
What to track
Bottom line: Your prescriber sets the dose. Food and milk are fine; the important step is checking every other medicine and supplement for interactions before the first dose.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Serious and sometimes fatal reactions from drug interactions through CYP3A4, including colchicine toxicity, muscle breakdown with simvastatin, lovastatin and atorvastatin, low blood pressure and acute kidney injury with calcium channel blockers such as amlodipine, verapamil, diltiazem and nifedipine (mostly in people 65 or older), and serious bleeding with warfarin.
QT prolongation and torsades de pointes, including fatalities; elderly people may be more susceptible.
Liver injury (hepatitis, with or without jaundice), usually reversible but occasionally fatal, generally in people with serious illness or other medicines.
Higher all-cause mortality one year or more after treatment in people with coronary artery disease, seen in one clinical trial.
Clostridioides difficile diarrhea, from mild to fatal colitis, which can start more than 2 months after the antibiotic.
Severe allergic and skin reactions, including anaphylaxis, Stevens-Johnson syndrome, toxic epidermal necrolysis and DRESS.
Worsening of myasthenia gravis or new myasthenic symptoms.
Who should avoid it
- People allergic to clarithromycin, erythromycin or any macrolide antibiotic: contraindicated
- People who had cholestatic jaundice or liver problems with past clarithromycin use: contraindicated
- People taking cisapride, pimozide, lomitapide, lovastatin, simvastatin, ergotamine, dihydroergotamine or lurasidone, or colchicine when kidney or liver function is impaired: contraindicated
- People with known QT prolongation, past torsades de pointes, uncorrected low potassium or magnesium, significant slow heart rate, or on other drugs known to prolong the QT interval or class IA or III antiarrhythmics: the label says to avoid it
- Pregnant people, unless no other treatment is appropriate
Pregnancy & breastfeeding
Pregnancy: the label says clarithromycin is not recommended in pregnancy except when no alternative therapy is appropriate, because it caused malformations in rats and mice at clinically relevant doses; human data are too limited to judge the risk. Breastfeeding: clarithromycin and its active metabolite pass into breast milk at less than 2% of the mother's weight-adjusted dose, and in a small observational study side effects in breastfed infants (rash, diarrhea, poor appetite, sleepiness) were similar to amoxicillin. The label says to weigh the benefits of breastfeeding with the mother's need for the drug. Talk with your prescriber.
Interactions
The label reports life-threatening and fatal interactions, even at recommended doses, because clarithromycin blocks colchicine's clearance. The combination is contraindicated with kidney or liver impairment, and otherwise the colchicine dose must be reduced. Tell your prescriber if you take colchicine for gout or another condition.
The label contraindicates these statins with clarithromycin because rhabdomyolysis has been reported; if clarithromycin cannot be avoided, the statin must be paused during the course. With atorvastatin the label caps the dose at 20 mg a day. Your prescriber will plan around your statin.
Red yeast rice contains monacolin K, which is lovastatin; 12 products tested contained 0.10 to 10.09 mg per capsule. The clarithromycin label contraindicates lovastatin because clarithromycin raises its level and rhabdomyolysis has been reported. Red yeast rice itself has not been studied with clarithromycin. Review it with your prescriber or pharmacist before the course, and report muscle pain, weakness or dark urine.
The label warns of serious bleeding and large rises in INR when clarithromycin is combined with warfarin, and says INR should be checked frequently. Tell whoever manages your warfarin before you start.
The clarithromycin label lists St. John's wort among reported CYP3A-based interactions and says to use caution. St. John's wort strongly speeds up CYP3A (activity rose 272% in one study), and the label says CYP3A inducers lower clarithromycin levels and could impair its effect, so another antibiotic should be considered. No study has measured clarithromycin levels with the herb. Tell your prescriber before the course if you take it.
Clarithromycin may kill the live bacteria in probiotic products: in lab tests, common probiotic Lactobacillus and Bifidobacterium strains, including GG and Bb12, were all sensitive to erythromycin, a closely related macrolide (clarithromycin itself was not tested). This may make a probiotic less useful but does not weaken the antibiotic. No trial has shown whether spacing the two apart helps or set the best gap; ask your pharmacist about timing.
Kefir's live microbes may be affected by the antibiotic. The dairy calcium issue that affects tetracyclines does not apply here: the clarithromycin label says it can be taken with milk. In a randomized trial of 125 children aged 1 to 5 taking antibiotics, kefir did not prevent antibiotic-associated diarrhea (18% versus 21.9% with placebo). Ask your pharmacist about timing if you drink it.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.
Warnings (2)
+ red yeast rice
highClarithromycin is a strong CYP3A4 inhibitor. Red yeast rice's main cholesterol-lowering compound, monacolin K, is the same molecule as lovastatin, which is cleared mainly by CYP3A4, and the clarithromycin label contraindicates lovastatin because of the risk of muscle injury, including rhabdomyolysis. Red yeast rice itself has not been studied with clarithromycin, and products vary widely in how much monacolin K they contain.
+ st. john's wort
highThe clarithromycin label lists St. John's wort among drugs with reported CYP3A-based interactions with clarithromycin and says to use the combination with caution, without saying which way the effect runs. St. John's wort strongly speeds up CYP3A, and the label says CYP3A inducers lower clarithromycin levels and raise its 14-OH metabolite, which could impair the antibiotic's effect, so an alternative antibiotic should be considered. No study has measured clarithromycin levels in people taking St. John's wort, so the size of any change is unknown.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I take red yeast rice while on clarithromycin?⌄
Review it with your prescriber or pharmacist first. Red yeast rice contains monacolin K, which is lovastatin, and the clarithromycin label contraindicates lovastatin because clarithromycin raises its level and muscle breakdown has been reported. Report any muscle pain, weakness or dark urine.
Can I take clarithromycin with milk or yogurt?⌄
Yes. The label says the tablets can be taken with or without food and with milk. The dairy calcium problem that affects tetracycline and fluoroquinolone antibiotics is not listed for clarithromycin.
Should I take a probiotic during the course?⌄
Clarithromycin may kill bacteria in probiotic products (lab tests used erythromycin, a closely related macrolide). No trial has shown whether spacing the two apart helps or set the best gap. Evidence that they prevent antibiotic side effects is mixed; kefir did not prevent diarrhea in a trial in young children. Ask your pharmacist.
Why does my pharmacist ask about all my other medicines?⌄
Clarithromycin is a strong blocker of the CYP3A4 enzyme, so it can raise other drugs to dangerous levels. The label lists serious reactions with colchicine, some statins, some blood pressure medicines (calcium channel blockers), warfarin and diabetes medicines, among others.
I have heart disease. Is clarithromycin safe for me?⌄
The label warns that one trial found higher mortality one year or more after treatment in people with coronary artery disease, and it also warns about QT prolongation. Your prescriber will weigh this against the benefit for your infection, so make sure they know your heart history.
References by claim
preventing MAC infection in advanced AIDS
Pierce et al., 1996 · PubMed (1996) link
Helicobacter pylori eradication (triple therapy)
stable coronary heart disease (off-label, not effective)
Safety
Clarithromycin tablets USP prescribing information · DailyMed (FDA label) link
Interaction: Red yeast rice
Interaction: Probiotics
Zhou et al., 2005 · PubMed (2005) link
Interaction: Kefir
Merenstein et al., 2009 · PubMed (2009) link
Interaction: St. John's wort
Huppertz et al., 2018 · PMC (2018) link
Track Clarithromycin with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
